Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function
Nasser A. Dhayat(University of Bern), Daniel G. Fuster(University of Bern), Olivier Devuyst(Cliniques Universitaires Saint-Luc), Martin Fiedler(University Hospital Ulm), Antoinette Péchère-Bertschi(University Hospital of Geneva), Menno Pruijm(University Medical Center Utrecht), Bruno Vogt(Hypertension Institute), Fred Paccaud(Institute of Social and Preventive Medicine), Georg Ehret(Johns Hopkins University), Michel Burnier(Gdańsk Medical University), Murielle Bochud(Centre universitaire de médecine générale et santé publique, Lausanne), Daniel Ackermann, Idris Guessous(University of Geneva), Pierre‐Yves Martin(University Hospital of Geneva), Alexander Leichtle(University of Bern), Markus G. Mohaupt, Belén Ponte(University Hospital of Geneva)
Cited by 70
Related Papers
Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2019|5.8k
Genome-wide association study of blood pressure and hypertension
|Nature Genetics|2009|1.4k
Evolving importance of kidney disease: from subspecialty to global health burden
|The Lancet|2013|1.2k
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
|The Lancet|2020|1.1k
Editor's Choice – Vascular Access: 2018 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS)
|European Journal of Vascular and Endovascular Surgery|2018|829